CONCORD, Ohio, July 1, 2014 /PRNewswire/ -- Ricerca Biosciences, a leading global provider of contract services for Life Science companies, today announced the recent successful completion of an EPA Office of Compliance FIFRA inspection, which resulted in no negative findings with respect to GLP compliance.
The inspection reviewed four completed studies and one active study. These were neurotoxicity, exposure, residue, metabolism and product chemistry studies. In addition to reviewing study-related records, the inspection included tours of the laboratories, as well as the standard inventory and
Tim Derrington, CEO of Ricerca, said, "A successful inspection such as this reinforces the quality and procedures we have in place to support clients' projects. The positive outcome of the extensive reviews and tours highlights the importance of GLP compliance to our clients and the regulatory agencies. Good study performance in a robust regulatory environment is essential for
buyers of outsourced services in terms of the confidence they have in Ricerca as the right partner to deliver on their needs."
About Ricerca Biosciences
Founded in 1986 and located in Concord, Ohio, Ricerca collaborates with global agrochemical and life science companies by providing a comprehensive, integrated suite of services to accelerate research, development and product registration in the global agrochemical and life science industries. Ricerca combines support for compound evaluation with analytical and chemical development expertise to bring candidates through all phases of development and registration. Its experienced teams are focused on making sense of science to help clients overcome the challenges of chemical development and compound registration to achieve their goals on time.
SOURCE Ricerca Biosciences